Medical Training AIDiagnosing and Managing HFpEF
You'll be able to work up a patient with suspected HFpEF using validated scoring tools and build a guideline-based treatment plan around comorbidities.
What this track covers
Heart failure with preserved ejection fraction is a heterogeneous syndrome driven by diastolic dysfunction, ventricular-arterial stiffening, and systemic inflammation, and it frequently overlaps with obesity, hypertension, diabetes, and atrial fibrillation. This track covers structured diagnosis using H2FPEF and HFA-PEFF frameworks, phenotype recognition, and current pharmacotherapy and comorbidity management strategies.
What you will practice
- Apply H2FPEF and HFA-PEFF scoring to a patient with exertional dyspnea and normal EF
- Differentiate HFpEF phenotypes: obesity-related, aging-related, AF-related, and infiltrative cardiomyopathy
- Sequence pharmacotherapy including SGLT2 inhibitors, MRAs, diuretics, and ARNi
- Interpret echo and biomarker data alongside invasive hemodynamics when the diagnosis is uncertain
- Coordinate comorbidity management for obesity, hypertension, diabetes, and AFib in the same care plan
Simulator scenario
A timed case of an older patient with obesity, atrial fibrillation, and exertional dyspnea who requires diagnostic workup and a phased treatment plan for suspected HFpEF.
Board question topics
- H2FPEF and HFA-PEFF score interpretation
- Echocardiographic and biomarker criteria for HFpEF
- First-line and add-on pharmacotherapy choices
- Phenotype-specific comorbidity management
Ask the tutor
The tutor only answers from licensed sources (FDA prescribing information, public guidelines and our own material) and says when it has none. Educational use only, never patient-specific advice.
Free during the beta. Sign in with your email, no password.
Start free